Antares Pharma Debt 2025

Antares Pharma Aktienanalyse

What does Antares Pharma do?

The company Antares Pharma Inc was founded in 1979 in Minneapolis, USA. It has since become a successful company in the field of drug development and marketing. The company has been listed on the NASDAQ since 2006. Antares Pharma is a pharmaceutical company specializing in the development of injectable medications. Their business model is to develop innovative injectable products that meet the needs of patients and doctors, and are able to improve their therapy experience and increase adherence. The company specializes in three areas: self-injection systems, automatic devices, and pharmaceutical products. The innovation power behind Antares Pharma's development work is an important factor in their success, as well as their skills in market research and marketing. One of the company's main products is the VIBEX Pen, an automatic injection device that can be operated by patients themselves and filled with various therapeutics. The device provides an easy and painless way to administer medications. The company also produces the Makena auto-injector, which is used in pregnancy treatment. Another important product is the QuickShot auto-injector, a proprietary device used by patients to administer hormone preparations, immunomodulators, and various other common therapeutics. Due to its many years of experience and good reputation in the market, Antares Pharma has strong collaborative relationships with the pharmaceutical industry. The company's customers include reputable pharmaceutical companies such as Pfizer, Teva, Merck, and Novartis, who utilize the company's expertise to bring their own products to the market. Antares Pharma is headquartered in Ewing Township, New Jersey, USA. The company employs a variety of research and development experts who are constantly working to develop new medications and therapy approaches. It has strengthened its position as a major player in the pharmaceutical market and its goal remains to continue creating innovative solutions in the industry. Answer: Antares Pharma Inc. is a successful pharmaceutical company specializing in the development and marketing of injectable medications. They are known for their innovative products that improve therapy experiences and increase adherence. With a strong presence in the pharmaceutical market, Antares Pharma collaborates with renowned companies and continues to strive for innovative solutions. Antares Pharma ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Debt Details

Understanding Antares Pharma's Debt Structure

Antares Pharma's total debt refers to the cumulative financial obligations the company owes to external parties. This can include short-term and long-term borrowings, bonds, loans, and other financial instruments. Assessing the company's debt levels is crucial for evaluating its financial health, risk profile, and ability to fund operations and expansions.

Year-to-Year Comparison

Analyzing Antares Pharma's debt structure over the years provides insights into the firm’s financial strategy and stability. A reduction in debt can indicate financial strength and operational efficiency, while an increase may signal growth investments or potential financial challenges ahead.

Impact on Investments

Investors pay close attention to Antares Pharma’s debt levels as they can influence the company’s risk and return profiles. Excessive debt can lead to financial strain, while moderate and well-managed debt can be a catalyst for growth and expansion, making it a critical aspect of investment evaluations.

Interpreting Debt Fluctuations

Shifts in Antares Pharma’s debt levels can be attributed to various operational and strategic factors. An increase in debt might be geared towards funding expansion projects or enhancing operational capacity, while a decrease may indicate profit realizations or an approach to minimize financial risk and leverage.

Frequently Asked Questions about Antares Pharma stock

What is the debt of Antares Pharma this year?

Antares Pharma has a debt level of 0 USD this year.

What was the debt of Antares Pharma compared to the previous year?

The debt of Antares Pharma has increased by 0% compared to the previous year dropped.

What are the consequences of high debt for investors in Antares Pharma?

High debt can pose a risk for investors of Antares Pharma, as it can weaken the company's financial position and hinder its ability to fulfill its obligations.

What are the consequences of low debt for investors of Antares Pharma?

Low debt means that Antares Pharma has a strong financial position and is able to fulfill its obligations without overburdening its finances.

How does an increase in debt from Antares Pharma affect the company?

An increase in debt of Antares Pharma can adversely affect the financial condition of the company and result in a higher burden on its finances.

How does a reduction of debt of Antares Pharma affect the company?

A reduction in debt of Antares Pharma can strengthen the company's financial position and improve its ability to meet its financial obligations.

What are some factors that influence the debt of Antares Pharma?

Some factors that can influence the debt of Antares Pharma include investments, acquisitions, operating costs, and revenue development.

Why are the debts of Antares Pharma so important for investors?

The debts of Antares Pharma are important for investors as they serve as an indicator of the company's financial stability. It provides investors with information on how the company fulfills its financial obligations.

What strategic measures can Antares Pharma take to change the debt?

To change the debt, Antares Pharma can take measures such as cost savings, increasing revenue, selling assets, making investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic actions to change its debt.

How much dividend does Antares Pharma pay?

Over the past 12 months, Antares Pharma paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Antares Pharma is expected to pay a dividend of 0 USD.

What is the dividend yield of Antares Pharma?

The current dividend yield of Antares Pharma is .

When does Antares Pharma pay dividends?

Antares Pharma pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Antares Pharma?

Antares Pharma paid dividends every year for the past 0 years.

What is the dividend of Antares Pharma?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Antares Pharma located?

Antares Pharma is assigned to the 'Health' sector.

Wann musste ich die Aktien von Antares Pharma kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Antares Pharma from 2/4/2025 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 2/4/2025.

When did Antares Pharma pay the last dividend?

The last dividend was paid out on 2/4/2025.

What was the dividend of Antares Pharma in the year 2024?

In the year 2024, Antares Pharma distributed 0 USD as dividends.

In which currency does Antares Pharma pay out the dividend?

The dividends of Antares Pharma are distributed in USD.